» Articles » PMID: 23767037

Technical Tips and Issues of Biliary Stenting, Focusing on Malignant Hilar Obstruction

Overview
Journal Clin Endosc
Date 2013 Jun 15
PMID 23767037
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Although there is no survival advantage, inoperable hilar cholangiocarcinoma managed by palliative drainage may benefit from symptomatic improvement. In general, biliary drainage is divided into endoscopic or percutaneous approaches and surgical drainage. Plastic or metal stent is the most preferred device for palliative drainage in endoscopic approach. Considering cost-effectiveness, use of metallic stent is preferred than plastic stents in patients with more than 3 months of life expectancy with inoperable malignant biliary obstruction. In patients with unresectable malignant hilar obstruction, the endoscopic approach with biliary stent placement by experts has been considered as the treatment of choice. However, the endoscopic management of hilar obstruction is often more challenging and complex than distal malignant biliary obstructions. There is still a lack of clear consensus on the use of plastic versus metal stents and unilateral versus bilateral drainage since the decision should be made under many grounds such as the volume of liver drainage more than 50%, life expectancy, and expertise of the facility.

Citing Articles

Endoscopic management of malignant biliary obstructions.

Binda C, Trebbi M, Coluccio C, Giuffrida P, Perini B, Gibiino G Ann Gastroenterol. 2024; 37(3):291-302.

PMID: 38779637 PMC: 11107404. DOI: 10.20524/aog.2024.0883.


Role of radiofrequency ablation in advanced malignant hilar biliary obstruction.

Takenaka M, Lee T Clin Endosc. 2023; 56(2):155-163.

PMID: 36646424 PMC: 10073846. DOI: 10.5946/ce.2022.218.


Editors' Choice of Noteworthy Clinical Endoscopy Publications in the First Decade.

Kim G, Kwon K, Park D, Han J Clin Endosc. 2021; 54(5):633-640.

PMID: 34510862 PMC: 8505185. DOI: 10.5946/ce.2021.216.


A preliminary single-center investigation of percutaneous biliary stenting in malignant hilar biliary obstruction: what impacts the clinical success and the long-term outcomes?.

Mao X, Wen F, Liang H, Sun W, Lu Z Support Care Cancer. 2021; 29(11):6781-6792.

PMID: 33990879 DOI: 10.1007/s00520-021-06271-0.


Serial insertion of bilateral uncovered metal stents for malignant hilar obstruction using an 8 Fr biliary system: a case series of 17 consecutive patients.

Hsieh J, Thosani A, Grunwald M, Nagula S, Bucobo J, Buscaglia J Hepatobiliary Surg Nutr. 2015; 4(5):348-53.

PMID: 26605283 PMC: 4607839. DOI: 10.3978/j.issn.2304-3881.2015.06.03.


References
1.
Chennat J, Waxman I . Initial performance profile of a new 6F self-expanding metal stent for palliation of malignant hilar biliary obstruction. Gastrointest Endosc. 2010; 72(3):632-6. DOI: 10.1016/j.gie.2010.04.037. View

2.
Chahal P, Baron T . Expandable metal stents for endoscopic bilateral stent-within-stent placement for malignant hilar biliary obstruction. Gastrointest Endosc. 2009; 71(1):195-9. DOI: 10.1016/j.gie.2009.08.006. View

3.
Pedersen F, Lassen A, Schaffalitzky de Muckadell O . Randomized trial of stent placed above and across the sphincter of Oddi in malignant bile duct obstruction. Gastrointest Endosc. 1998; 48(6):574-9. DOI: 10.1016/s0016-5107(98)70038-0. View

4.
De Palma G, Pezzullo A, Rega M, Persico M, Patrone F, Mastantuono L . Unilateral placement of metallic stents for malignant hilar obstruction: a prospective study. Gastrointest Endosc. 2003; 58(1):50-3. DOI: 10.1067/mge.2003.310. View

5.
Raijman I . Biliary and pancreatic stents. Gastrointest Endosc Clin N Am. 2004; 13(4):561-92, vii-viii. DOI: 10.1016/s1052-5157(03)00069-2. View